Literature DB >> 27746982

Dual bronchodilation and exacerbations of COPD.

Mario Cazzola1, Josuel Ora1, Ermanno Puxeddu1.   

Abstract

Entities:  

Year:  2016        PMID： 27746982      PMCID： PMC5059243          DOI： 10.21037/jtd.2016.08.92

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  22 in total

Review 1.  Non-neuronal cholinergic airway epithelium biology.

Authors:  Wolfgang Kummer; Gabriela Krasteva-Christ
Journal:  Curr Opin Pharmacol       Date:  2014-03-27       Impact factor: 5.547

Review 2.  Distribution of receptor targets in the lung.

Authors:  Peter J Barnes
Journal:  Proc Am Thorac Soc       Date:  2004

Review 3.  A Systematic Review With Meta-Analysis of Dual Bronchodilation With LAMA/LABA for the Treatment of Stable COPD.

Authors:  Luigino Calzetta; Paola Rogliani; Maria Gabriella Matera; Mario Cazzola
Journal:  Chest       Date:  2016-02-26       Impact factor: 9.410

Review 4.  Defining phenotypes in COPD: an aid to personalized healthcare.

Authors:  Andrea Segreti; Emanuele Stirpe; Paola Rogliani; Mario Cazzola
Journal:  Mol Diagn Ther       Date:  2014-08       Impact factor: 4.074

5.  Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPD.

Authors:  Jadwiga A Wedzicha; Donald Banerji; Kenneth R Chapman; Jørgen Vestbo; Nicolas Roche; R Timothy Ayers; Chau Thach; Robert Fogel; Francesco Patalano; Claus F Vogelmeier
Journal:  N Engl J Med       Date:  2016-05-15       Impact factor: 91.245

Review 6.  Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans.

Authors:  I Wessler; C J Kirkpatrick
Journal:  Br J Pharmacol       Date:  2008-05-26       Impact factor: 8.739

7.  Withdrawal of inhaled glucocorticoids and exacerbations of COPD.

Authors:  Helgo Magnussen; Bernd Disse; Roberto Rodriguez-Roisin; Anne Kirsten; Henrik Watz; Kay Tetzlaff; Lesley Towse; Helen Finnigan; Ronald Dahl; Marc Decramer; Pascal Chanez; Emiel F M Wouters; Peter M A Calverley
Journal:  N Engl J Med       Date:  2014-09-08       Impact factor: 91.245

8.  Translational Study Searching for Synergy between Glycopyrronium and Indacaterol.

Authors:  Mario Cazzola; Luigino Calzetta; Andrea Segreti; Francesco Facciolo; Paola Rogliani; Maria Gabriella Matera
Journal:  COPD       Date:  2014-09-15       Impact factor: 2.409

9.  LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD.

Authors:  Nanshan Zhong; Changzheng Wang; Xiangdong Zhou; Nuofu Zhang; Michael Humphries; Linda Wang; Chau Thach; Francesco Patalano; Donald Banerji
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-06-05

10.  Pharmacological characterisation of the interaction between glycopyrronium bromide and indacaterol fumarate in human isolated bronchi, small airways and bronchial epithelial cells.

Authors:  Mario Cazzola; Luigino Calzetta; Ermanno Puxeddu; Josuel Ora; Francesco Facciolo; Paola Rogliani; Maria Gabriella Matera
Journal:  Respir Res       Date:  2016-06-13
View more
  2 in total

1.  The Challenges of Precision Medicine in COPD.

Authors:  Mario Cazzola; Luigino Calzetta; Paola Rogliani; Maria Gabriella Matera
Journal:  Mol Diagn Ther       Date:  2017-08       Impact factor: 4.074

2.  Insight into Inhibitory Mechanism of PDE4D by Dietary Polyphenols Using Molecular Dynamics Simulations and Free Energy Calculations.

Authors:  Veronika Furlan; Urban Bren
Journal:  Biomolecules       Date:  2021-03-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.